Search results

Explore 30 years of CRO evolution, from preclinical roots to integrated, flexible partnerships—and how Altasciences is shaping the future of drug development.

Ken Phares demystifies ICH Q14 & Q2(R2) guidelines with practical strategies for analytical procedure development, risk-based method design, and lifecycle management.

Discover seven tips from expert toxicologist and consultant Robin Guy on tackling key challenges for in vitro NAMs studies, from data integrity to regulatory acceptance.

Discover four key topics to expect to cover during your first meeting with a contract research organization, to set yourself up for a long-lasting partnership.